Dyne Therapeutics, Inc. 是一間肌肉疾病公司,是一家生物技術公司,專注於在美國推進針對遺傳性肌肉疾病的療法。該公司總部位於麻薩諸塞州沃爾瑟姆。
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
營業支出
2026-06-30
$181.66M
2026-03-31
$125.27M
2025-12-31
$115.6M
2025-09-30
$113.89M
淨利潤
2026-06-30
-$178.55M
2026-03-31
-$120.85M
2025-12-31
-$111.95M
2025-09-30
-$108.04M
淨利潤率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$-1.08
2026-03-31
$-0.73
2025-12-31
$-0.73
2025-09-30
$-0.76
息稅折舊攤銷前利潤
2026-06-30
-$173.4M
2026-03-31
-$116.1M
2025-12-31
-$101.22M
2025-09-30
-$104.61M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
項目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
營業收入
$0
$0
$0
$0
營業支出
$181.66M
$125.27M
$115.6M
$113.89M
淨利潤
-$178.55M
-$120.85M
-$111.95M
-$108.04M
淨利潤率
--
--
--
--
每股收益
$-1.08
$-0.73
$-0.73
$-0.76
息稅折舊攤銷前利潤
-$173.4M
-$116.1M
-$101.22M
-$104.61M
有效稅率
--
--
--
--
常見問題
DYN stock represents shares of common stock in a publicly traded company. DYN is the ticker symbol used on U.S. stock exchanges. To identify the exact company behind the ticker, verify the issuer's name and business description on the DYN stock detail page or in regulatory filings. The ticker alone does not convey the company's fundamentals, so reviewing the profile and latest disclosures is the most reliable way to understand what DYN represents.
The industry classification for DYN depends on the company's primary business operations and how data providers categorize it. The most accurate and current industry designation is shown in the DYN company profile on this page. Because industry classifications can differ across providers, checking the profile alongside the company's latest annual report gives the clearest picture of the sector and specific industry DYN operates in.
Recent performance for DYN is best measured using the latest price, percentage change, and trading volume displayed in the DYN quote section on this page. Looking at returns over multiple periods—such as one day, one month, and year to date—provides context beyond a single session. For the most current figures, refer to the live DYN data shown here, since performance changes continuously during market hours.
Evaluating DYN's valuation involves comparing its market price with fundamental measures such as earnings, revenue, and book value, often expressed through ratios like P/E, price-to-sales, and price-to-book. These metrics are most useful when compared with peers in the same industry and with DYN's own historical ranges. Current valuation inputs for DYN are available on this page, and detailed financials can be found in the company's filings.
DYN may be eligible for pre-market and after-hours trading sessions, depending on the exchange and your brokerage's offerings. Extended-hours trading typically has lower liquidity and wider spreads than the regular session, which can affect execution prices. Availability, session times, and any eligibility restrictions for DYN are best confirmed with your broker and the exchange listing details rather than assumed.
Earnings details for DYN—including quarterly and annual results, revenue, net income, and earnings per share—are typically available in the company's investor relations materials and filings with the SEC, plus the earnings section of this stock page. If reported figures are not displayed here, rely on the latest official release or filing. Reported earnings can influence DYN's stock price and how investors assess the business.